Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
71 hedge funds and large institutions have $331M invested in Syneron Medical Ltd in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 8 closing their positions.
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
18% more capital invested
Capital invested by funds: $280M → $331M (+$51.3M)
6% more funds holding
Funds holding: 67 → 71 (+4)
5% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$43M |
| 2 |
BC
Broadfin Capital
New York
|
+$9.54M |
| 3 |
CAD
Craig A. Drill
|
+$2.25M |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.51M |
| 5 |
HM
HealthCor Management
New York
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$6.98M |
| 2 |
SAM
Steinberg Asset Management
New York
|
-$2.36M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$2.11M |
| 4 |
HC
Hourglass Capital
Houston,
Texas
|
-$1.87M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$1.77M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Jane Street
New York
| – | -$154K | -12,550 | Closed |
|
77
Acadian Asset Management
Boston,
Massachusetts
| – | -$113K | -9,157 | Closed |
|
78
Group One Trading
Chicago,
Illinois
| – | -$2.96K | -250 | Closed |
|
79
Barclays
London,
United Kingdom
| – | -$12 | -1 | -8% |
|
ELOS Hedge Fund Activity: Q1 2014 in Review
71 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2014, worth a combined $331M — up 18% from $280M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ELOS positions and 8 closed out — a net gain of 4 holders — while 22 added to existing stakes and 21 trimmed.
The largest buyer was Senvest Management, opening a new position worth an estimated $43M. The largest seller was Brandes Investment Partners, cutting an estimated $6.98M.
- 71 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2014, up from 67 in Q4 2013.
- Funds reported $331M of Syneron Medical Ltd stock for Q1 2014, up 18% quarter-over-quarter.
- 12 funds opened new Syneron Medical Ltd positions in Q1 2014 and 8 closed out, a net change of +4 holders.
- The largest Syneron Medical Ltd buyer in Q1 2014 was Senvest Management, an estimated $43M added.
- The largest Syneron Medical Ltd seller in Q1 2014 was Brandes Investment Partners, an estimated $6.98M sold.
Based on aggregated 13F filings for Q1 2014.